Drug prices bizarre high concentration of tenders into a monopoly feast

Under normal circumstances, drugs must be sold at high prices first to increase the bid price, and this process is nothing more than "public relations." In the words of the medical representative, “First of all, we must know who the experts who have approved the tender price are, and we must open up the relationship.” Needless to say, the centralized procurement of medicines by provincial agencies is a key step. This kind of high monopoly based on the credibility of the government may not only generate cheaper prices, but may also generate huge space for power rent-seeking and corruption. Unfortunately, what happened to us was the latter.

The ex-factory price of drugs that can be investigated by reporters and the experts and officials who represent the government’s power to exercise pricing rights may not be unknown. The real situation can only be that the centralized tendering of drugs has been manipulated into a feast of monopoly: because the public has no way of understanding the selection and bidding conditions of the various aspects of the tendering process, the absolute power creates an absolute high drug price.

Since the government departments are not good at concentrating on the procurement of drugs, it is necessary to think: Who can better represent the interests of the patients instead of sitting on the bench with drug companies?

Excessive drug prices have been discussed for many years but have not been truly resolved. It is not uncommon for high-priced drugs to be sold at prices several times, dozens or even hundreds of times higher than the ex-factory price. In this regard, there are comments that: drug prices are bizarrely high proof, centralized tendering into a monopoly feast, pushing up drug prices.